MSCI Inc. (NYSE:MSCI) COO Cd Baer Pettit sold 2,500 shares of the stock in a transaction that occurred on Monday, April 5th. The stock was sold at an average price of $430.66, for a total value of $1,076,650.00. Following the completion of the transaction, the chief operating officer now owns 261,802 shares in the company, valued at approximately $112,747,649.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.
Cd Baer Pettit also recently made the following trade(s):
- On Thursday, February 4th, Cd Baer Pettit sold 2,500 shares of MSCI stock. The stock was sold at an average price of $420.52, for a total transaction of $1,051,300.00.
Shares of MSCI stock opened at $437.45 on Thursday. The stock’s fifty day simple moving average is $419.92 and its 200 day simple moving average is $404.89. MSCI Inc. has a one year low of $286.05 and a one year high of $455.81. The firm has a market cap of $36.20 billion, a price-to-earnings ratio of 65.39 and a beta of 0.91.
The firm also recently declared a quarterly dividend, which was paid on Friday, February 26th. Shareholders of record on Friday, February 19th were given a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.71%. The ex-dividend date of this dividend was Thursday, February 18th. MSCI’s dividend payout ratio (DPR) is currently 48.45%.
Several equities analysts have commented on the stock. Barclays increased their target price on shares of MSCI from $360.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, December 17th. UBS Group upgraded shares of MSCI from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $452.00 to $463.00 in a research note on Monday, February 1st. Deutsche Bank Aktiengesellschaft began coverage on shares of MSCI in a research report on Thursday, March 18th. They set a “buy” rating and a $475.00 target price for the company. Finally, Morgan Stanley raised their target price on MSCI from $422.00 to $448.00 and gave the company an “equal weight” rating in a report on Friday, January 29th. Three investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $453.71.
Institutional investors and hedge funds have recently made changes to their positions in the business. Shilanski & Associates Inc. lifted its stake in shares of MSCI by 1.0% in the fourth quarter. Shilanski & Associates Inc. now owns 3,165 shares of the technology company’s stock worth $1,413,000 after acquiring an additional 30 shares during the period. CX Institutional increased its position in shares of MSCI by 53.1% during the fourth quarter. CX Institutional now owns 98 shares of the technology company’s stock worth $44,000 after buying an additional 34 shares during the period. Intellectus Partners LLC raised its stake in MSCI by 3.6% during the fourth quarter. Intellectus Partners LLC now owns 995 shares of the technology company’s stock worth $444,000 after buying an additional 35 shares during the last quarter. Penserra Capital Management LLC boosted its position in MSCI by 26.5% during the fourth quarter. Penserra Capital Management LLC now owns 172 shares of the technology company’s stock valued at $76,000 after acquiring an additional 36 shares during the last quarter. Finally, AMG National Trust Bank grew its holdings in MSCI by 0.3% during the 4th quarter. AMG National Trust Bank now owns 11,808 shares of the technology company’s stock worth $5,272,000 after acquiring an additional 37 shares during the period. 89.29% of the stock is currently owned by hedge funds and other institutional investors.
MSCI Company Profile
MSCI Inc, together with its subsidiaries, provides investment decision support tools for the clients to manage their investment processes worldwide. The company operates through Index, Analytics, and All Other segments. The Index segment primarily provides indexes for use in various areas of the investment process, including indexed product creation, such as ETFs, mutual funds, annuities, futures, options, structured products, over-the-counter derivatives; performance benchmarking; portfolio construction and rebalancing; and asset allocation, as well as licenses GICS and GICS Direct.
Read More: How to Trade Using Analysts Ratings
Receive News & Ratings for MSCI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MSCI and related companies with MarketBeat.com's FREE daily email newsletter.